CompletedNot applicableNCT05142059
Fall Risk Assessment in a Population of Charcot-Marie-Tooth Disease Type 1A (CMT 1A) by Timed Up and Go Test
Studying Charcot-Marie-Tooth disease type 1A
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Clermont-Ferrand
- Principal Investigator
- Emmanuel CoudeyreUniversity Hospital, Clermont-Ferrand
- Intervention
- Exploratory physiopathology study, including non-invasive functional explorations carried out in patients with Charcot-Marie-Tooth disease type 1A(diagnostic_test)
- Enrollment
- 42 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2024
Study locations (1)
- CHU de Clermont-Ferrand, Clermont-Ferrand, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05142059 on ClinicalTrials.govOther trials for Charcot-Marie-Tooth disease type 1A
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07140614A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A.Novartis Pharmaceuticals
- RECRUITINGNANCT07049588Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A DiseaseAssistance Publique Hopitaux De Marseille
- RECRUITINGNCT07476365A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease (CMT1A)University Medical Center Goettingen
- RECRUITINGNCT06794489Longitudinal Biomarkers With Selected Outcome Measures In CMTUniversity Medical Center Goettingen
- ACTIVE NOT RECRUITINGNANCT02596191Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and BiomarkersAssistance Publique Hopitaux De Marseille